PATENT CLAIM ANALYSIS

Application Number: 16089872
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "400000"]

Abstract:
A therapeutic agent for inflammatory bowel diseases comprising as an active ingredient a compound represented by the formula (I) wherein R represents a hydrogen atom or a [1-(isobutyryloxy)ethoxy]carbonyl group or the like, or a pharmacologically acceptable salt thereof.

Claim (Index 13):
The method of  claim 8 , wherein the inflammatory bowel disease is ulcerative colitis, Crohn's disease, intestinal Behcet's disease, hemorrhagic rectal ulcer or pouchitis.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 97.0
- Lexical Diversity: 1.19512
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15736933', '14107043', '13550366', '14182611', '13055096']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7746384729407852
- 35 USC 102 Novelty (BERT): 0.5358275463182681
- Combined Prediction Score: 0.7507573802785336
- Mean Citation Score: 267.2838780000001
- Max Citation Score: 361.9184
- Similarity Product: 200.4021458137512

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test